• EMAIL
  • PRINT
  • PDF
  • Bookmark and Share

Increasing Shareholder Value For A Biotech Client

A foreign biotechnology company turned to McCarter to improve corporate governance and increase shareholder value by terminating certain executive contracts, initiating litigation to void overreaching employment agreements, and revising employment agreements for its remaining executive officers. Our team advised on a capital raise, a listing on a U.S. national stock exchange, and a new public offering. Chris Mayer assisted on the litigation, Joel Horowitz worked on the employment agreements, and Sheldon Misher took on the securities issues.